Background/Aims Cholestatic liver diseases including primary biliary cholangitis (PBC) are associated with active hepatic fibrogenesis, which ultimately progresses to cirrhosis. Activated hepatic stellate cells (HSCs) are the main fibrogenic effectors in response to cholangiocyte damage. JCAD regulates cell proliferation and malignant transformation in nonalcoholic steatoheaptitis-associated hepatocellular carcinoma (NASH-HCC). However, its participation in cholestatic fibrosis has not been explored yet.
Methods Serial sections of liver tissue of PBC patients were stained with immunofluorescence. Hepatic fibrosis was induced by bile duct ligation (BDL) in wild-type (WT), global JCAD knockout mice (JCAD-KO) and HSC-specific JCAD knockout mice (HSC-JCAD-KO), and evaluated by histopathology and biochemical tests. In situ-activated HSCs isolated from BDL mice were used to determine effects of JCAD on HSC activation.
Results In consistence with staining of liver sections from PBC patients, immunofluorescent staining revealed that JCAD expression was identified in smooth muscle α-actin (α-SMA)-positive fibroblast-like cells and was significantly up-regulated in WT mice with BDL. JCAD deficiency remarkably ameliorated BDL-induced hepatic injury and fibrosis, as documented by liver hydroxyproline content, when compared to WT mice with BDL. Histopathologically, collagen deposition was dramatically reduced in both JCAD-KO and HSC-JCAD-KO mice compared to WT mice, as visualized by Trichrome staining and semi-quantitative scores. Moreover, JCAD deprivation significantly attenuated in situ HSC activation and reduced expression of fibrotic genes after BDL.
Conclusions JCAD deficiency effectively suppressed hepatic fibrosis induced by BDL in mice, and the underlying mechanisms are largely through suppressed Hippo-YAP signaling activity in HSCs.
Underestimated and Overlooked Factors in PBC Progression: Bacterial and Fungal Infections Yaxin Zhu, Sumeng Li, Shiqi Li, Yichen Wang, Yanqin Du, Xin Zheng, Jun Wu International Journal of Molecular Sciences.2026; 27(6): 2766. CrossRef
Activated hepatic stellate cells maintain hepatic bile acid homeostasis through paracrine FGF10/FGFR2 signaling Santie Li, Gaozan Tong, Mei Xue, Leyi Shen, Kunxuan Zhu, Jianjun Feng, Junfu Fan, Junjie Lu, Xiaojing Yi, Luhai Wang, Jiaqi Liang, Weitao Cong, Xiaokun Li Journal of Hepatology.2026; 85(2): 314. CrossRef
Integrating network pharmacology and experimental validation to uncover the therapeutic mechanisms of Chaigui decoction in Schistosoma japonicum-induced liver fibrosis Kaiyuan Deng, Xinyao Du, Qiao Liu, Zhi Lan, Fengning Wang, Yulin Cao, Song Xu, Xiaoli Deng, Xiang Wu, Guangjie Li, Yujiao Yang, Xin Wang, Fengyu Yang, Qingyuan Gu, Qingyang Yao, Liangzheng Zou, Wanning Wang, Mijia Yuan, Teng Zhong, Pei Huang, Yonghua Zhou Acta Tropica.2026; 280: 108160. CrossRef
From network prediction to in vivo validation: luteolin attenuates cholestatic liver injury in association with PI3K/Akt/GSK-3β signalling modulation Yuxin Wu, Shiji Gong, Xin Wu, Wei Wang, Dongming Zhang, Jianxin Jia Naunyn-Schmiedeberg's Archives of Pharmacology.2026;[Epub] CrossRef
Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review Jiwen Cheng Frontiers in Cell and Developmental Biology.2026;[Epub] CrossRef
Notoginsenoside R1 alleviates cholestatic liver fibrosis through modulation of the intestinal FXR-FGF15 axis and bile acid homeostasis Min Yang, Qiaolian Ma, Bairong Yang, Jie Li, Weiyu Chang, Xiuming Cui, Ben Niu, Feng Ge Biochemical Pharmacology.2026; 253: 118312. CrossRef
Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells Xixi Zeng, Yanhong Liao, Weiyi Cheng Journal of Gastroenterology and Hepatology.2025; 40(1): 294. CrossRef
Hepatic Stellate Cell TM4SF1 Accelerates Hepatic Fibrosis Progression via Interacting With the Tyrosine Kinase c-Src Shenglu Liu, Peng Tan, Jiatong Chen, Zhiwei Huang, Bingyu Ren, Zhonghao Jiang, Boyuan Gu, Wenhao Yu, Lei Sun, Yingjun Chen, Jian Ruan, Wenguang Fu Cellular and Molecular Gastroenterology and Hepatology.2025; 19(10): 101559. CrossRef
JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway Li Zhang, Yong‐Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong‐Hua Wang, Yu‐Li Wang, Xiu‐Ping Liu, Fa‐Xing Yu, Jian Wu Clinical and Translational Medicine.2024;[Epub] CrossRef
JCAD, a new potential therapeutic target in cholestatic liver disease Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 166. CrossRef
Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances” Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 297. CrossRef
Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu Clinical and Molecular Hepatology.2024; 30(2): 279. CrossRef
Primary liver cancer is one of the most common cancer worldwide. Hepatocellular carcinoma (HCC) in particular, is the second leading cause of cancer deaths in the world. The Hippo signaling pathway has emerged as a major oncosuppressive pathway that plays critical roles inhibiting hepatocyte proliferation, survival, and HCC formation. A key component of the Hippo pathway is the inhibition of yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) transcription factors by the Hippo kinase cascade. Aberrant activation of YAP or TAZ has been found in several human cancers including HCC. It is also well established that YAP/TAZ activation in hepatocytes causes HCC in mouse models, indicating that YAP/TAZ are potential therapeutic targets for human liver cancer. In this review, we summarize the recent findings regarding the multifarious roles of Hippo/YAP/TAZ in HCC development, and focus on their cell autonomous roles in controlling hepatocyte proliferation, differentiation, survival and metabolism as well as their non-cell autonomous in shaping the tumor microenvironment.
Citations
Citations to this article as recorded by
Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita Biochemistry and Biophysics Reports.2026; 45: 102403. CrossRef
Therapeutic potential of diosgenin in hepatocellular carcinoma through molecular mechanisms and nanodelivery strategies Charmi Jyotishi, Mansi Patel, Suresh Prajapati, Reeshu Gupta Discover Oncology.2026;[Epub] CrossRef
Long noncoding RNA H19 in liver development and disease Diego Elias Montoya-Durango, Leila Gobejishvili Cellular Signalling.2026; 142: 112413. CrossRef
FAM216A Promotes Hepatocellular Carcinoma Proliferation and Invasion through the PLK1/ERK Signaling Pathway Peng Ma, Ying Hao, Yuefeng Zhang, Weiguo Tang, Wei Wang, Zuo Muo, Kaihuan Yu, Weixing Wang Genetic Testing and Molecular Biomarkers.2026; 30(3): 55. CrossRef
Deciphering the signaling landscape of YAP in the tumor microenvironment—Insights into hepatocellular carcinoma progression Prachi Sharma, Shaikh Maryam Ghufran, Bornika Roy, Sampa Ghose, Subhrajit Biswas FEBS Letters.2026; 600(7): 1006. CrossRef
The Regulation and Function of Hippo/YAP Pathway in Cancer Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun The FASEB Journal.2026;[Epub] CrossRef
Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies Penghui He, Sinan Xie, Kunlin Xie, Fengwei Gao, Yunshi Cai, Yan Huang, Chang Liu, Hong Wu, Yinghao Lyu, Tian Lan MedComm.2026;[Epub] CrossRef
LINC01184 promotes hepatocellular carcinoma development via the miR-193a-3p/DCAF7 axis Bing Wang, Xun Zou, Yuanchu Xiao Archives of Biochemistry and Biophysics.2026; 781: 110821. CrossRef
Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity Yichi Xu, Bo Wen, Dai Zhang, Fangxin Tang, Shu Liu Current Oncology Reports.2026;[Epub] CrossRef
LATS kinase activity and tumor suppressor function are regulated by a second autophosphorylation site Ruxin Jin, Zhenxing Zhong, Rui Zhu, Anlan Zhang, Jian Li, Fa-Xing Yu, Yu Wang Journal of Biological Chemistry.2026; 302(7): 113177. CrossRef
Comparative Analysis of Classical and Emerging Experimental Animal Models of Liver Injury: A Comprehensive Review Ibtehal Nasser Salman, Roaa Khaled Jabbar, Israa Emad, Zain Al‐Abidin Ahmed Hassan, Abeer Mahdi Harbi, Aseel Yass Khudhair, Malak Ali Mohammed Hussein, Ali Majid Hamid, Mahdi Abd Al Amir, Mustafa Wafi Ali, Mohamed M. Khalifa Journal of Applied Toxicology.2026;[Epub] CrossRef
Machine learning-driven evaluation of protein kinase D3 as a co-diagnostic biomarker in hepatocellular carcinoma Jing Li, Yifan Zhao, Yicheng Ma, Bei Xie, Li Huang, Haitang Yang, Xingyuan Ma, Haohua Deng, Shuaiyang Wang, Chanjuan Sun, Pengfei Cao, Linjing Li Journal of Zhejiang University-SCIENCE B.2026; 27(7): 788. CrossRef
Reprogramming hepatocellular carcinoma: Nanomedicine at the crossroads of molecular targets and smart delivery Khaled Mahmoud, Mahmoud Teaima, Yasmeen Attia, Jingjing Sun, Mohamed El-Nabarawi, Shady Swidan Colloids and Surfaces B: Biointerfaces.2026; 268: 115981. CrossRef
p21-activated kinase 4 drives hepatic stellate cell activation and liver fibrosis through the phosphorylation of YAP at T428 Gil-Hwan Kim, Hyunsoo Rho, Chang Hun Lee, You-Jung Hong, Yongdo Park, Hwang Chan Yu, Mi-Young Song, Hye Jin Jo, Eun Joo Kang, Ri Han, Song Yi Yu, Ekihiro Seki, Yoonji Lee, Sangkyu Lee, Eun Ju Bae, Byung-Hyun Park, Chang Yeob Han Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression Farzin Mirzaei-nasab, Ahmad Majd, Yousef Seyedena, Nazanin Hosseinkhan, Najma Farahani, Mehrdad Hashemi Practical Laboratory Medicine.2025; 45: e00464. CrossRef
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications Mohamed J. Saadh, Hanan Hassan Ahmed, Radhwan Abdul Kareem, Ashok Kumar Bishoyi, R. Roopashree, Debasish Shit, Renu Arya, Abhishek Sharma, Kakhramon Khaitov, Hayder Naji Sameer, Ahmed Yaseen, Zainab H. Athab, Mohaned Adil Molecular Biology Reports.2025;[Epub] CrossRef
CXCR7 promoted proliferation, migration and invasion in HCC Cells by inactivating Hippo-YAP signaling Genwang Wang, Yu Pang, Nan Li, Yongfeng Hui, Dong Jin Discover Oncology.2025;[Epub] CrossRef
Wogonin potentiates the irradiation effect on hepatocellular carcinoma by activating the Hippo-Yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway Xiao Xu, Yan Cheng, Zeyu Yang, Yong Yin, Yonghong Qian, Haiyu Yang, Shusheng Zhu, Hu Tian, Yanshuang Zhuang, Shimin Zhu, Pingjin Yang, Songbing Qin, Weigan Shen International Immunopharmacology.2025; 157: 114740. CrossRef
DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery Wei Lan, Haibo Liao, Qingfeng Chen, Lingzhi Zhu, Yi Pan, Yi-Ping Phoebe Chen Briefings in Bioinformatics.2024;[Epub] CrossRef
Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea Biomolecules.2024; 14(6): 656. CrossRef
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation Mengjia Lin, Xiaoyun Zheng, Jianing Yan, Fei Huang, Yilin Chen, Ran Ding, Jinkai Wan, Lei Zhang, Chenliang Wang, Jinchang Pan, Xiaolei Cao, Kaiyi Fu, Yan Lou, Xin-Hua Feng, Junfang Ji, Bin Zhao, Fei Lan, Li Shen, Xianglei He, Yunqing Qiu, Jianping Jin Nature Communications.2024;[Epub] CrossRef
Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer Manasi Kotulkar, Diego Paine-Cabrera, Udayan Apte Seminars in Liver Disease.2024; 44(03): 383. CrossRef
Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review) Shenghao Li, Liyuan Hao, Na Li, Xiaoyu Hu, Huimin Yan, Erhei Dai, Xinli Shi International Journal of Oncology.2024;[Epub] CrossRef
Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing Perihan Hamdy Kassem, Iman Fawzy Montasser, Ramy Mohamed Mahmoud, Rasha Ahmed Ghorab, Dina A. AbdelHakam, Marium EL Sayed Ahmad Fathi, Marwa A. Abdel Wahed, Khaled Mohey, Mariam Ibrahim, Mohamed El Hadidi, Yasmine M. Masssoud, Manar Salah, Arwa Abugable, BMC Medical Genomics.2024;[Epub] CrossRef
Targeting the Hippo- Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Signaling Pathway in Primary Liver Cancer Therapy Yina Wang, Liangyou Rui Onco.2024; 4(3): 217. CrossRef
M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-βcatenin/Hippo pathway Chao Zhang, Xiaoxiao Wang, Huangqin Song, Junlong Yuan, Xiaomin Zhang, Yiran Yuan, Zhuangqiang Wang, Zhang Lei, Jiefeng He Cell Biology and Toxicology.2024;[Epub] CrossRef
Hepatitis C virus nonstructural protein 4B induces lipogenesis via the Hippo pathway Chen Zou, Hongxi Tan, Jun Zeng, Minqi Liu, Guangping Zhang, Yi Zheng, Zhanfeng Zhang Archives of Virology.2023;[Epub] CrossRef
Crosstalk between miRNAs and DNA Methylation in Cancer Michela Saviana, Patricia Le, Lavender Micalo, Daniel Del Valle-Morales, Giulia Romano, Mario Acunzo, Howard Li, Patrick Nana-Sinkam Genes.2023; 14(5): 1075. CrossRef
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way Shiji Fang, Liyun Zheng, Xiaoxiao Chen, Xiaoju Guo, Yiming Ding, Ji Ma, Jiayi Ding, Weiqian Chen, Yang Yang, Minjiang Chen, Zhongwei Zhao, Jianfei Tu, Jiansong Ji Hepatology International.2023; 17(6): 1500. CrossRef
Maternal-Periconceptional Vitamin B12 Deficiency in Wistar Rats Leads to Sex-Specific Programming for Cardiometabolic Disease Risk in the Next Generation Praveen Singh, Lovejeet Kaur, Subhoshree Ghose, Swati Varshney, Vislavath Jyothi, Sourav Ghosh, Pujitha Kommineni, Shamsudheen KV, Vinod Scaria, Sridhar Sivasubbu, Giriraj Ratan Chandak, Shantanu Sengupta The Journal of Nutrition.2023; 153(12): 3382. CrossRef
The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP Zelin Tian, Chen Xu, Weixiang He, Zhibin Lin, Wenjie Zhang, Kaishan Tao, Rui Ding, Xuan Zhang, Kefeng Dou Cancer Letters.2023; 577: 216439. CrossRef
Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment Noor N. Al-Bzour, Ayah N. Al-Bzour, Obada E. Ababneh, Moayad M. Al-Jezawi, Azhar Saeed, Anwaar Saeed International Journal of Molecular Sciences.2023; 24(22): 16505. CrossRef
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim American Journal of Gastroenterology.2022; 117(2): 288. CrossRef
TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome Maryam Naghib, Ashraf Kariminik, Mohammad Kazemi Arababadi Viral Immunology.2022; 35(1): 15. CrossRef
CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity Yan Fu, Hongfei Ci, Wei Du, Qiongzhu Dong, Huliang Jia Pharmaceutics.2022; 14(2): 275. CrossRef
Construction and Comprehensive Analysis of a circRNA-miRNA-mRNA Regulatory Network to Reveal the Pathogenesis of Hepatocellular Carcinoma Meile Mo, Bihu Liu, Yihuan Luo, Jennifer Hui Juan Tan, Xi Zeng, Xiaoyun Zeng, Dongping Huang, Changhua Li, Shun Liu, Xiaoqiang Qiu Frontiers in Molecular Biosciences.2022;[Epub] CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2022; 14(3): 711. CrossRef
Parafibromin Is Highly Expressed in Hepatocellular Carcinoma and Its Expression Correlates with Poor Prognosis Min-Kyung Kim Journal of Clinical Medicine.2022; 11(7): 1773. CrossRef
CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling Zibo Chen, Tao Yuan, Fangjie Yan, Song Ye, Qin Xie, Bo Zhang, Nengmin Lin, Qiaojun He, Bo Yang, Hong Zhu BMC Cancer.2022;[Epub] CrossRef
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors Hyunjung Park, Hyerin Park, Jiyeon Baek, Hyuk Moon, Simon Weonsang Ro Biology.2022; 11(4): 585. CrossRef
Hippo in Gastric Cancer: From Signalling to Therapy Lornella Seeneevassen, Pierre Dubus, Caroline Gronnier, Christine Varon Cancers.2022; 14(9): 2282. CrossRef
Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618. CrossRef
MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul Frontiers in Genetics.2022;[Epub] CrossRef
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway Geofrey Mahiki Mranda, Zhi-Ping Xiang, Jun-Jian Liu, Tian Wei, Yinlu Ding Frontiers in Oncology.2022;[Epub] CrossRef
Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data Lianghe Yu, Ningjia Shen, Yan Shi, Xintong Shi, Xiaohui Fu, Shuang Li, Bin Zhu, Wenlong Yu, Yongjie Zhang Frontiers in Immunology.2022;[Epub] CrossRef
Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis Ran Cheng, Xiaoyuan Xu Journal of Hepatocellular Carcinoma.2022; Volume 9: 987. CrossRef
Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p Samer A. Tadros, Yasmin M. Attia, Nadine W. Maurice, Sally A. Fahim, Fatma M. Abdelwahed, Samar Ibrahim, Osama A. Badary International Journal of Molecular Sciences.2022; 23(24): 15904. CrossRef
Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway Shili Ning, Yuzhuo Chen, Guangzhi Wang, Yongtai Liu, Yingchi Yang, Zhongtao Zhang Frontiers in Oncology.2022;[Epub] CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer Kyung Joo Cho, Sun Yeong Shin, Hyuk Moon, Beom Kyung Kim, Simon Weonsang Ro Translational Oncology.2021; 14(9): 101158. CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef
Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu Cell Biology International.2021; 45(11): 2161. CrossRef
FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway Yingzhi Lu, Zhenxin Wang, Ling Zhou, Zhaoming Ma, Jianguo Zhang, Yan Wu, Yan Shao, Yunyun Yang, Lubna H. Tahtamouni Analytical Cellular Pathology.2021; 2021: 1. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
The Hippo Pathway: A Master Regulatory Network Important in Cancer Qiuping Liu, Xiaomeng Liu, Guanbin Song Cells.2021; 10(6): 1416. CrossRef
MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer Na-Hyun Lee, So Jung Kim, Jeongeun Hyun Biomedicines.2021; 9(4): 347. CrossRef
Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer Liyu Cao, Cong Zhang, Qingqing Wu, Zhenzhen Bai, Jing Chen Oncology Letters.2021;[Epub] CrossRef
First
Prev
